RCI-001U

N/A

Report date: 2024/12/27 15:40:59

Base Information

Drug NameRCI-001U
Drug Alias NameRCI-001URCI001U
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRas-related C3 botulinum toxin substrate 1 inhibitors
TargetsRas-related C3 botulinum toxin substrate 1
Therapy Area/IndicationsCorneal Ulcer
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRudacure Co LtdGachon University
China Registration ClassN/A

Develop Information

Active CompaniesHanlim Pharmaco LtdRudacure Co Ltd
Inactive CompaniesN/A
Active IndicationsCorneal Ulcer
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A